Advanced search×

Evidence for a link between parasite genotype and outcome of infection with Entamoeba histolytica.

J Clin Microbiol 45(2):285-9 (2007) PMID 17122021 PMCID 1829016

The factors determining whether a person infected with Entamoeba histolytica develops disease remain obscure. To investigate whether the parasite genome contributes to the outcome, we have investigated the distribution of parasite genotypes among E. histolytica-infected individuals in Bangladesh. Samples were obtained from individuals who either were asymptomatic, had diarrhea/dysentery, or had developed a liver abscess. Genotypes were determined by using six tRNA-linked polymorphic markers, and their distributions among the three sample groups were evaluated. A significant population differentiation in the genotype distribution was found for four of the six individual markers as well as for the combined genotypes, suggesting that the parasite genome does contribute in some way to the outcome of infection with E. histolytica. The markers themselves do not indicate the nature of the underlying genetic differences, but they may be linked to loci that do have an impact on the outcome of infection.

DOI: 10.1128/JCM.01335-06
Version: za2963e q8za7 q8zb3 q8zc9 q8zd2 q8ze4 q8zf8 q8zg6

Similar articles you may find interesting…

  1. Motile invaded neutrophils in the small intestine of Toxoplasma gondii-infected mice reveal a potential mechanism for parasite spread.

    Proc Natl Acad Sci U S A (2013) PMID 23650399

    We lack important information about how the parasite interacts with the host immune system in the intestine. We used two-photon laser-scanning microscopy in conjunction with a mouse model of oral T. gondii infection to address this issue. T. gondii established discrete foci of infection in the small...
  2. The study design and rationale of the randomized controlled trial: translating COPD guidelines into primary care practice.

    BMC Fam Pract 14(1):56 (2013) PMID 23641803

    We will also examine the use of a patient activation tool - 'MyLungAge' - to prompt patients at risk for or who have COPD to request spirometry confirmation and to request support for smoking cessation if a smoker. DISCUSSION: Using a multi-modal intervention of patient activation and a technology-s...
  3. THE FETAL SAFETY OF MACROLIDES.

    Antimicrob Agents Chemother (2013) PMID 23650169

    Use of macrolides in the first trimester of pregnancy is not associated with an increased risk of major malformations. Exposure in the third trimester is not likely to increase neonatal risks for pyloric stenosis or intussusception in a clinically meaningful manner....